7.0-T Magnetic Resonance Imaging Characterization of Acute Blood-Brain-Barrier Disruption Achieved with Intracranial Irreversible Electroporation

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Garcia, Paulo A ^a   Rossmeisl, John H ^b   Robertson, John L ^b   Olson, John D ^c   Johnson, Annette J ^c   Ellis, Thomas L ^c   Davalos, Rafael V ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL DEATH; CONTROLLED STUDY; ELECTRIC FIELD; ELECTRIC POTENTIAL; HISTOPATHOLOGY; IMAGE RECONSTRUCTION; IN VIVO STUDY; IRREVERSIBLE ELECTROPORATION; MALE; MEMBRANE DAMAGE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT;

EID: 84870609666     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050482     Document Type: Article

References (28)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
2. Hochberg FH, Pruitt A, (1980) Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911.
3. Barajas RF Jr, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, et al. (2012) Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol 14: 942-954.
4. Saraswathy S, Crawford F, Lamborn K, Pirzkall A, Chang S, et al. (2009) Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. Journal of Neuro-Oncology 91: 69-81.
5. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, et al. (2010) Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255: 415-425.
6. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, et al. (2006) Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. European Journal of Cancer Supplements 4: 3-13.
7. Salford LG, Persson BR, Brun A, Ceberg CP, Kongstad PC, et al. (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 194: 938-943.
8. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, et al. (2011) Preclinical Validation of Electrochemotherapy as an Effective Treatment for Brain Tumors. Cancer Research 71: 3753-3762.
9. Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, et al. (2007) Tumor ablation with irreversible electroporation. PLoS ONE 2: e1135.
10. Davalos RV, Mir LM, Rubinsky B, (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33: 223-231.
11. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B, (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53: 1409-1415.
12. Appelbaum L, Ben-David E, Sosna J, Nissenbaum Y, Goldberg SN, (2012) US Findings after Irreversible Electroporation Ablation: Radiologic-Pathologic Correlation. Radiology 262: 117-125.
13. Ben-David E, Appelbaum L, Sosna J, Nissenbaum I, Goldberg SN, (2012) Characterization of Irreversible Electroporation Ablation in In Vivo Porcine Liver. Am J Roentgenol 198: W62-W68.
14. Davalos RV, Rubinsky B, (2008) Temperature considerations during irreversible electroporation. International Journal of Heat and Mass Transfer 51: 5617-5622.
15. Lee EW, Loh CT, Kee ST, (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6: 287-294.
16. Ellis TL, Garcia PA, Rossmeisl JH Jr, Henao-Guerrero N, Robertson J, et al. (2011) Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. J Neurosurg 114: 681-688.
17. Garcia PA, Rossmeisl JH, Neal II RE, Ellis TL, Olson J, et al. (2010) Intracranial nonthermal irreversible electroporation: In vivo analysis. J Membr Biol 236: 127-136.
18. Garcia PA, Pancotto T, Rossmeisl JH, Henao-Guerrero N, Gustafson NR, et al. (2011) Non-thermal irreversible electroporation (N-TIRE) and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient. Technol Cancer Res Treat 10: 73-83.
19. Hjouj M, Last D, Guez D, Daniels D, Lavee J, et al. (2011) Electroporation-Induced BBB Disruption and Tissue Damage Depicted by MRI. Neuro-Oncology 13: 114.
20. Frigeni V, Miragoli L, Grotti A, Lorusso V, (2001) Comparative Study Between Gadobenate Dimeglumine and Gadobutrol in Rats with Brain Ischemia: Evaluation of Somatosensory Evoked Potentials. Investigative Radiology 36: 561-572.
21. Noce AL, Frigeni V, Demicheli F, Miragoli L, Tirone P, (1999) EEG Evaluation. Investigative Radiology 34: 262.
22. Köhrmann M, Struffert T, Frenzel T, Schwab S, Doerfler A, (2012) The Hyperintense Acute Reperfusion Marker on Fluid-Attenuated Inversion Recovery Magnetic Resonance Imaging Is Caused by Gadolinium in the Cerebrospinal Fluid. Stroke 43: 259-261.
23. Howles GP, Bing KF, Qi Y, Rosenzweig SJ, Nightingale KR, et al. (2010) Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood-brain barrier with ultrasound. Magn Reson Med 64: 995-1004.
24. Hirschberg H, Zhang MJ, Gach HM, Uzal FA, Peng Q, et al. (2009) Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol 95: 317-329.
25. Garcia PA, Rossmeisl JH Jr., Neal RE 2nd, Ellis TL, Davalos RV (2011) A Parametric Study Delineating Irreversible Electroporation from Thermal Damage Based on a Minimally Invasive Intracranial Procedure. Biomed Eng Online 10: 34.
26. Chopra A (2004-2010) Evans Blue-diethylenetriamine-N,N,N",N"-pentaacetic acid-gadolinium. Molecular Imaging and Contrast Agent Database (MICAD). 10/25/2007 ed: Bethesda (MD): National Center for Biotechnology Information (US).
27. Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, et al. (2001) Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer 84: 565-570.
28. Mahmood F, Hansen RH, Agerholm-Larsen B, Jensen KS, Iversen HK, et al. (2011) Diffusion-Weighted MRI for Verification of Electroporation-Based Treatments. Journal of Membrane Biology 240: 131-138.